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Alex N. Bastick1*, Jos Runhaar1, Janneke N. Belo2 and Sita M.A. Bierma-Zeinstra1Abstract
Introduction: We performed a systematic review of prognostic factors for the progression of symptomatic knee
osteoarthritis (OA), defined as increase in pain, decline in physical function or total joint replacement.
Method: We searched for available observational studies up to January 2015 in Medline and Embase according
to a specified search strategy. Studies that fulfilled our initial inclusion criteria were assessed for methodological
quality. Data were extracted and the results were pooled, or if necessary summarized according to a best
evidence synthesis.
Results: Of 1,392 articles identified, 30 met the inclusion criteria and 38 determinants were investigated. Pooling
was not possible due to large heterogeneity between studies. The best evidence synthesis showed strong evidence
that age, ethnicity, body mass index, co-morbidity count, magnetic resonance imaging (MRI)-detected infrapatellar
synovitis, joint effusion and baseline OA severity (both radiographic and clinical) are associated with clinical knee
OA progression. There was moderate evidence showing that education level, vitality, pain-coping subscale resting,
MRI-detected medial femorotibial cartilage loss and general bone marrow lesions are associated with clinical knee
OA progression. However, evidence for the majority of determinants was limited (including knee range of motion
or markers) or conflicting (including age, gender and joint line tenderness).
Conclusion: Strong evidence was found for multiple prognostic factors for progression of clinical knee OA. A
large variety in definitions of clinical knee OA (progression) remains, which makes it impossible to summarize the
evidence through meta-analyses. More research on prognostic factors for knee OA is needed using symptom
progression as an outcome measure. Remarkably, only few studies have been performed using pain progression
as an outcome measure. The pathophysiology of radiographic factors and their relation with symptoms should be
further explored.Introduction
Osteoarthritis (OA) is one of the most common chronic
diseases and is one of the leading causes of pain and
disability worldwide. Amongst patients with OA, the in-
cidence and prevalence of knee OA is the highest [1].
Consequently, many studies have been and are being
performed to determine prognostic factors for knee OA.
Previously, Belo et al. [2] published a systematic review
determining all prognostic factors for knee OA. Their
literature search was performed up to 2003 and none of* Correspondence: a.bastick@erasmusmc.nl
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any medium, provided the original work is pr
(http://creativecommons.org/publicdomain/zerothe included articles had used clinical outcome measures
to assess knee OA progression. An update of the review
by Belo et al. [3]. has recently been performed by the
same authors, but again only focuses on radiographic
progression of knee OA when a clear discordance be-
tween radiographic and symptomatic knee OA has
formerly been established [4]. Also, symptomatic pro-
gression of knee OA is most relevant for the patient and
the physician in clinical practice. Therefore, we have
chosen to perform a systematic review of prognostic
factors for the symptomatic (i.e., clinical) progression of
knee OA. To our knowledge, this is the first systematic
review of its kind.rticle distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in
operly credited. The Creative Commons Public Domain Dedication waiver
/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Methodological quality assessment criteria
Quality criteria Score
Study population
A) Description of source population 1
B) Valid inclusion and exclusion criteria 1
C) Sufficient description of baseline characteristics 1
Follow-up
D) Follow-up of at least 1 year 1
E) Prospective or retrospective data collection 1
F) Loss to follow-up ≤20 % 1
G) Information about loss to follow-up (selective for
age, sex or severity)
1
Exposure
H) Exposure assessment blinded for the outcome 1
I) Exposure measured identically in the studied population
at baseline and follow-up
1
Outcome
J) Outcome assessment blinded for exposure 1
K) Outcome measured identically in the studied population
at baseline and follow-up
1
Analysis
L) Measure of association or measures of variance given 1
M) Adjusted for age, sex and severity 1
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Literature search
Our search was performed in Medline and Embase up
to January 2015. The keywords used were: knee, osteo-
arthritis (or arthritis, or arthrosis, or degenerative joint
disease), progression (or prognosis, or precipitate, or
predictive), clinical (or symptomatic) and case–control
(or cohort, or longitudinal, or follow-up). All abstracts
and, if necessary, full texts of the identified references
were reviewed for inclusion independently by two au-
thors (ANB and JR or JNB). The following inclusion
criteria were used: ≥85 % of the patients used in the ana-
lyses for OA progression had clinical (i.e., American Col-
lege of Rheumatology (ACR) or Osteoarthritis Research
Society International Atlas (OARSI) criteria) or radio-
graphic evidence of knee OA at baseline (equivalent to a
Kellgren and Lawrence (K/L) score ≥2 at baseline); the
study investigated determinants associated with the clin-
ical progression of knee OA; a specific clinical outcome
measure was appointed, i.e., pain, function or knee joint
replacement; the study had either a case–control or co-
hort design with a minimal follow-up period of 1 year;
the full text of the article was available; and the study
was written in English, Dutch, German or French. Stud-
ies that merely observed incidence of knee OA were ex-
cluded. Studies determining magnetic resonance imaging
(MRI) features as prognostic factors were included as
long as a clinical outcome measure was applied. Another
reason for exclusion was if the study population had an
underlying pathology (e.g., rheumatoid arthritis, bacterial
infection) of the joint. Finally, inclusion of articles was
extended if a relevant article was detected when screen-
ing the references of included articles.
Methodological quality
The methodological quality assessment criteria were based
on previously described criteria by Lievense et al. [5],
Scholten-Peeters et al. [6], and Altman [7] (Table 1). All
included articles were scored independently by two au-
thors (ANB and JR or JNB) with a maximum score of 13
points. In case of disagreement, the authors arranged an
appointment to achieve consensus. Noteworthy is that we
only scored the articles based on the data that were pub-
lished in the manuscripts; hence, characteristics of the
selected population under study that were published else-
where were not incorporated in the quality score.
Data extraction
Study population characteristics, observed risk factors,
definitions of knee OA progression and measures of
association or correlations, including odds ratios (OR),
relative risks (RR), hazard ratios (HR) or regression coef-
ficients and their 95 % confidence intervals (CI) were ex-
tracted and are presented in this review.Evidence synthesis
OR, RR or HR were pooled when clinical homogeneity
in the study population, measured determinants and
assessed outcome was assumed (using Review Manager
(RevMan). Version 5.3. Copenhagen: The Nordic Cochrane
Centre, The Cochrane Collaboration, 2014). In the absence
of clinical homogeneity, a best evidence synthesis was used
to summarize the data. The level of evidence was based on
the updated guidelines by Furlan et al. [8] and was divided
into the following levels: A) strong evidence, i.e., consistent
(>75 %) findings amongst multiple (≥2) high-quality stud-
ies; B) moderate evidence, i.e., findings in one high-quality
study and consistent (>75 %) findings in ≥2 low-quality
studies; C) limited, evidence, i.e., findings in one high-
quality study or consistent findings in ≥3 low-quality stud-
ies; and D) conflicting or inconclusive evidence, i.e., <75 %
of the studies reported consistent findings, or the results
were only based on one study. Articles were scored as high
quality when they had a quality score ≥9 (>65 % of the
maximal attainable score). Only statistically significant as-
sociations were considered as associated prognostic factors
in the best evidence synthesis.
Sensitivity analysis
If we were forced to perform a best evidence synthesis,
we conducted a sensitivity analysis to check whether
differences in sample size (cut-off N = 200) could have
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large variances in follow-up (cut-off 24 months) duration
could have led to different conclusions. Finally, we
checked whether our conclusions could have been influ-
enced by differences in definitions for clinical OA (cOA)
progression in the included articles; for instance, knee
joint replacement as opposed to pain progression or func-
tion decline.
Results
Studies included
Of the 1,392 articles identified using our search strategy,
30 articles met the inclusion criteria [9–38]. Three
reviewers scored a total of 390 items for the methodo-
logical quality assessment and agreed on 351 items
(90 %; κ 0.71). The 39 disagreements were resolved in a
single consensus meeting.
Of the 30 articles 20 were of high quality and scored
in the range of 9–13. Almost all studies had a prospect-
ive research design. Three definitions of OA were used
for the inclusion of participants: 17 studies used the K/L
criteria, 11 articles applied the ACR criteria and 2 stud-
ies used the OARSI. Four of the studied populations
contained more men than women, all other studies con-
tained more women. A full overview of these results, in-
cluding study sample sizes and follow-up durations, is
presented in Table 2. Fifteen different definitions were
used to define progression of cOA, including knee joint
replacement, symptom severity on the Western Ontario
and McMasters osteoarthritis index (WOMAC) scales
for pain, function or stiffness and visual analogue scale
(VAS) for pain. The definitions for cOA progression are
presented in the corresponding tables which are dis-
cussed below.
Study results
We obtained 38 different determinants. We grouped our
findings into two pragmatically chosen categories: pa-
tient characteristics and disease characteristics. A full
overview of the determinants and their potential associa-
tions to clinical knee OA progression are presented in
Tables 3 and 4. Some authors reported statistically signifi-
cant associations to OA progression, but used p values as
indications of association. We chose to only present OR,
RR, HR or regression coefficients as measures of associa-
tions in our tables, but we have tabulated whether there
was a significant association found in an article or not. All
measures of association were eventually included in the
evidence syntheses.
Patient characteristics
Patient characteristics are show in Table 3. Two studies
found significant positive associations between age and
cOA progression [29, 30]. One study [25] found noassociation and three studies [15, 20, 21], two of which are
from the same cohort, found a slight negative association.
Muraki et al. found no association between gender
and cOA progression [25]. Collins et al. found significant
associations for low moderate, high moderate and severe
pain trajectories compared to no pain trajectory (not all
data in Table 3) [15].
Holla et al. determined a significantly increased risk
for symptom progression in non-western participants
compared to western participants [20]. Collins et al. found
similar results comparing whites with non-whites [15].
They also found increased risks for cOA progression for a
lower education level, as did Riddle et al. [29].
Six authors performed analyses determining the asso-
ciation between body mass index (BMI) and cOA pro-
gression [15, 20, 21, 25, 29, 34]. Five out of six analyses
found statistically significant positive associations [15,
20, 21, 25, 29]; Sharma et al. found no association [34].
Riddle and Stratford investigated the influence of body
weight change (either a reduction or gain) and cOA pro-
gression [31]. They found that only at least 10 % change
in bodyweight significantly influences the risk of cOA
progression. Henriksen et al. found no association for
change in peak knee joint compressive forces and cOA
progression [18]. A decrease in peak knee force (or un-
loader) was defined as decrease in body mass, unchanged
walking speed, and a decreased knee extensor moment.
Five authors studied co-morbidity as a determinant for
cOA progression [15, 20, 21, 27, 37]. Holla et al. found
no association for co-morbidity count in one study [20],
but found an association in another study within the
same cohort [21]. Collins et al. [15], Pisters et al. [27] and
van Dijk et al. [37] found that an increase in co-morbidity
count led to a significant increase in cOA progression.
Collins et al. found that depression (Center for Epide-
miologic Studies Depression Scale ≥16) increased the
risk for a unfavorable pain trajectory [15]. Sharma et al.
studied the association between a mental health survey
score and the progression of limitations in physical
functioning [34]. A higher mental health score (i.e., bet-
ter mental health) was associated with a decreased risk
for a poor outcome on the Physical function scale of the
Western Ontario and McMaster osteoarthritis index
(WOMAC-PF) scale. Riddle et al. found a reversed asso-
ciation per unit of the Short form survey instrument for
the mental component summary (SF-12 MCS) score and
knee joint surgery [30].
van Dijk et al. [37] and Holla et al. [21] reported a
favorable effect of high vitality on cOA progression.
Alschuler et al. found associations for the coping strat-
egy catastrophizing and praying or hoping (not all data
presented in Table 3) [9]. Holla et al. found no association
for frequent use of the pain coping strategy distraction,
but found a significant association for infrequent use of
Table 2 Study characteristics of the included studies (n = 30)
Author [ref.] year Follow-up
months
Definition of OA
for inclusion
Age, years Women, % No. of
patients
Quality
score
A B C D E F G H I J K L M
Amin [10] 2009 30 ACR criteria 69 42 265 13 1 1 1 1 1 1 1 1 1 1 1 1 1
Tanamas [35] 2010 24 K/L 63.2 ± 10.3 51 109 13 1 1 1 1 1 1 1 1 1 1 1 1 1
Cicuttini [14] 2004 24 K/L 63.1 ± 10.3 58 113 12 1 1 1 1 1 1 0 1 1 1 1 1 1
Hill [19] 2007 30 ACR criteria 66.7 ± 9.2 41 233 12 1 1 1 1 1 1 0 1 1 1 1 1 1
Holla [21] 2014 60 ACR criteria 56.0 ± 5.1 81.3 697 12 1 1 1 1 1 1 1 0 1 1 1 1 1
Tanamas [36] 2010 24 ACR criteria 63.2 ± 10.3 70 109 12 1 1 1 1 1 1 1 0 1 1 1 1 1
Berry [12] 2010 24 ACR criteria 63.7 ± 10.3 58 117 11 1 1 1 1 1 1 1 0 1 0 1 1 1
Henriksen [18] 2013 12 K/L 63 82 157 11 1 0 1 1 1 1 1 1 1 0 1 1 1
Yang [38] 2015 36 K/L 43 % >65 58 1,625 11 1 0 1 1 1 1 0 1 1 1 1 1 1
Alschuler [9] 2013 12 K/L 65.3 ± 9.0 59 797 10 1 1 1 1 1 0 0 0 1 1 1 1 1
Amin [11] 2008 30 ACR criteria 67 ± 9 43 265 10 1 1 1 1 1 1 1 0 1 0 1 1 1
Collins [15] 2014 72 K/L 62 ± 9 59 1,753 10 1 0 1 1 1 0 0 1 1 1 1 1 1
Holla [20] 2010 24 ACR criteria 56.0 ± 5.1 80 832 10 1 1 1 1 1 1 1 0 1 0 1 1 1
Lapane [22] 2015 48 K/L 70 58 1,846 10 1 0 1 1 1 0 0 1 1 1 1 1 1
Larsson [23] 2012 90 OARSI 50 (32–73) 18 74 10 1 1 1 1 1 1 0 0 1 1 1 1 1
Laslett [24] 2014 60 K/L 61 100 323 10 1 1 1 1 1 0 0 1 1 0 1 1 1
Muraki [25] 2012 40 K/L 68.7 ± 11.3 75 1,313 10 1 1 1 1 1 1 0 0 1 1 1 1 1
Podsiadlo [28] 2014 72 ACR criteria 63.9 57 114 10 1 0 1 1 1 1 1 0 1 0 1 1 1
Riddle [30] 2012 48 OARSI 62 58 4,670 10 1 1 1 1 1 1 1 0 1 0 1 1 1
Roemer [32] 2014 60 K/L 64.2 ± 8.4 58 398 10 1 1 1 1 1 0 0 1 1 1 1 1 0
Bruyere [13] 2005 45.6 ACR criteria 64.7 ± 7.0 70 139 9 1 0 1 1 1 1 1 0 1 0 1 1 0
Conaghan [16] 2010 36 K/L 67 ± 10 73 531 9 1 1 1 1 1 1 0 0 1 0 1 1 0
Sharma [34] 2003 36 K/L 68.6 ± 10.8 73 236 9 1 1 1 1 1 1 0 0 1 0 1 1 0
Eckstein [17] 2013 48 K/L 58 64 97 8 1 0 1 1 1 0 1 0 1 1 1 0 0
Oak [26] 2013 48 K/L 61.2 ± 9.1 53 942 8 1 0 1 1 1 0 0 0 1 0 1 1 1
Riddle [29] 2009 24 K/L 61.6 ± 9.3 60 778 8 1 1 1 1 1 0 0 0 1 0 1 1 0
Scher [33] 2008 36 K/L 51 63 73 8 1 0 0 1 1 1 0 0 1 1 1 1 0
van Dijk [37] 2011 36 ACR criteria 65.9 ± 8.3 74 174 8 1 0 1 1 1 1 0 0 1 0 1 1 0
Pisters [27] 2012 60 ACR criteria 66.1 ± 8.5 74 216 7 1 0 1 1 1 0 0 0 1 0 1 1 0
Riddle [31] 2013 33 K/L 62.7 ± 8.6 63 1,410 7 1 0 1 1 1 0 0 0 1 0 1 1 0
A–M represent criteria scores (see Table 1). ACR American College of Rheumatology, K/L Kellgren and Lawrence score, OA, osteoarthritis, OARSI Osteoarthritis
Research Society International Atla
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and Holla et al. [21] found significant associations for
cOA progression when applying the pain coping strategy
resting (i.e., avoidance of activity).
Holla et al. found an association between morning
stiffness of the knee joint (<30 minutes) and a poor
outcome on the WOMAC-PF scale [20]. Muraki et al.
found a significant association between previous knee
injury and incident knee pain at follow-up in patients
with K/L ≥2 at baseline [25].
Riddle et al. determined a significant association for
participants with a history of knee surgery, but noassociations for history of hip replacement surgery
[30]. Riddle et al. [30] and Lapane et al. [22] found no
associations for frequent medication use. Laslett et al.
found an association between bisphosphonate use and
decrease in the numeric rating scale (NRS) after 3 and
4 years, but not after 5 years; however, medication
compliance did drop remarkably in this study by the
fifth year [24]. They found no association for WOMAC
scores. Yang et al. found no clinically significant differ-
ences between users and non-users of glucosamine
and/or chondroitin in WOMAC pain, stiffness or
function [38].
Table 3 Patient characteristics studied as determinants for clinical knee OA progression in the included studies
Determinant Author [ref.] year Instrument of measurement Definition of knee OA
progression
OR/RR/HR/β (95 % CI) Association
with OA
prognosis*
Age Muraki [25] 2012 Per 5 years increase Incident knee pain at follow-
up (baseline K/L ≥2)
OR 1.01 (0.95–1.07) o
(N = 10,043) Holla [20] 2010 Continuous (years) Progressing/remaining in
poor WOMAC-PF quintiles
OR 0.97 (0.94–1.00) –
Holla [21] 2014 Continuous (years) Poor vs good outcome
WOMAC-PF trajectory
OR 0.94 (0.88–1.00) –
Collins [15] 2014 Continuous (years) Severe vs no pain WOMAC
pain trajectory
OR 0.92 (0.89–0.96) –
Riddle [29] 2009 Continuous (years) Knee joint surgery OR 1.07 (1.02–1.11) +
Riddle [30] 2012 Continuous (years) Knee joint surgery RR 1.04 (1.01–1.23) +
Female sex Collins [15] 2014 Female vs male Severe vs no pain WOMAC
pain trajectory
OR 3.0 (1.5–6.2) +
(N = 3,066) Muraki [25] 2012 Female vs male Incident knee pain at follow-
up (baseline K/L ≥2)
OR 1.32 (0.94–1.84) o
Ethnicity Collins [15] 2014 Non-white vs white Severe vs no pain WOMAC
pain trajectory
OR 3.3 (1.7–6.6) +
(N = 2,585) Holla [20] 2010 Non-western vs western Progressing/remaining in
poor WOMAC-PF quintiles
OR 4.03 (1.06–15.4) +
Education level Collins [15] 2014 <College≥ college Severe vs no pain WOMAC
pain trajectory
OR 5.1 (2.3–11.2) +
(N = 2,531) Riddle [29] 2009 ≤ High school graduate Knee joint surgery OR 2.40 (1.09–5.28) +
Body mass index
(N = 4,857)
Holla [20] 2010 Continuous Progressing/remaining in
poor WOMAC-PF quintiles
OR 1.06 (1.02–1.11) +
Sharma [34] 2003 Per 5 unit increase Progressing/remaining in
poor WOMAC-PF quintiles
OR 1.15 (0.89–1.46) o
Collins [15] 2014 Obese vs non-obese Severe vs no pain WOMAC
pain trajectory
OR 2.3 (1.2–4.4) +
Holla [21] 2014 Continuous Moderate vs good outcome
WOMAC-PF trajectory
OR 1.12 (1.07–1.18) +
Muraki [25] 2012 Per 5 units increase Incident knee pain at follow-
up (baseline K/L ≥2)
OR 1.54 (1.90–1.82) +
Riddle [29] 2009 ≤30 vs >30 kg/m2 Knee joint surgery OR 2.66 (1.20–5.92) +
Bodyweight change Riddle [31] 2013 ≥–10 % vs –4.9 to +4.9 % β 4.07 (1.49–6.65) –
(N = 1,410) –9.9 to –5 % vs –4.9
to +4.9 %
Increase self-reported
limitations (WOMAC-PF)
β 0.01 (–1.87 to 1.89) o
+5 to +9.9 % vs –4.9
to +4.9 %
Increase in pain (WOMAC);
similar results, not tabulated
β 1.08 (–0.91 to 3.07) o
≥ + 10 % vs –4.9 to +4.9 % β –5.36 (–8.74 to –2.00) +
Knee compression
force
Henriksen [18] 2013 Change in peak knee joint
compressive force
Change in KOOS-4 LSMD –2.4 (–6.8 to 1.9) o
(N = 157) Change in walking speed,
m/s
LSMD –0.01 (–0.05 to 0.03) o
Co-morbidity count Holla [20] 2010 ≥3 vs none Progressing/remaining in
poor WOMAC-PF quintiles
OR 1.53 (0.93–2.53) o
(N = 3,672) Holla [21] 2014 ≥3 vs < 3 Poor vs good outcome
WOMAC-PF trajectory
OR 3.28 (1.62–6.64) +
Collins [15] 2014 ≥1 vs 0 Severe vs no pain WOMAC
pain trajectory
OR 2.0 (1.0–3.9) +
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Pisters [27] 2012 Per unit CIRS increase Increase in self-reported
limitations (WOMAC-PF)
β 3.69 (1.66–8.23) +
Van Dijk [37] 2011 Per unit CIRS increase Increase in self-reported
limitations (WOMAC-PF)
β –0.147 (not provided) +
Increase in performance-
based limitations (TWT)
β 0.150 (not provided) +
Mental health Collins [15] 2014 CES-D ≥16 vs CES-D < 16 Severe vs no pain WOMAC
pain trajectory
OR 8.8 (3.1–25.2) +
(N = 6,659) Sharma [34] 2003 Per 5 points score Progressing/remaining in
poor WOMAC-PF quintiles
OR 0.58 (0.39–0.86) –
Riddle [30] 2012 Per unit SF-12 MCS score Knee joint surgery RR 1.07 (1.04–1.10) +
Vitality Holla [21] 2014 Per unit SF-36 HS score Poor vs good outcome
WOMAC-PF trajectory
OR 0.96 (0.94–0.98) –
(N = 871) Van Dijk [37] 2011 Per unit SF-36 MOS score Increase in self-reported
limitations (WOMAC-PF)
β 0.157 (not provided) –
Increase in performance-
based limitations (TWT)
β –0.229 (not provided) –
Pain coping Alschuler [9] 2013 CSQ subscale praying or
hoping
≥20 % change in combined
NRS and WOMAC-PF score
Not provided +
(N = 1,048) CSQ subscale
catastrophizing
≥20 % change in combined
NRS or WOMAC-PF score
Not provided +
Holla [20] 2010 PCI subscale distraction Progressing/remaining in
poor WOMAC-PF quintiles
OR 1.26 (0.98–1.62) o
PCI subscale worrying OR 0.63 (0.66–0.73) –
Holla [21] 2014 PCI subscale resting Poor vs good outcome
WOMAC-PF trajectory
OR 1.16 (1.02–1.31) +
Pisters [27] 2012 PCI subscale resting Increase in self-reported
limitations (WOMAC-PF)
β 23.3 (1.93–280.7) +
Increase in performance-
based limitations (TWT)
β 3.13 (1.95–5.03) +
Morning stiffness Holla [20] 2010 <30 minutes, yes vs no Progressing/remaining in
poor WOMAC-PF quintiles
OR 1.37 (0.99–1.88) o
(N = 832)
Knee injury Muraki [25] 2012 Previous knee injury Incident knee pain at
follow-up (baseline K/L ≥2)
OR 2.91 (1.26–6.82) +
(N = 1,313)
Knee surgery Riddle [30] 2012 History of knee surgery Knee joint surgery RR 2.04 (1.33–3.13) +
(N = 4,670)
Pain medication use Riddle [30] 2012 For pain, aching or
stiffness
Knee joint surgery RR 1.64 (0.87–3.12) o
(N = 6,516) Lapane [22] 2015 NSAID usage vs not MICD of WOMAC pain β –0.88 (–2.22 to 0.46) o
MICD of WOMAC-PF β –4.27 (–8.84 to 0.31) o
MICD of WOMAC stiffness β –0.72 (–1.56 to 0.12) o
Bisphosphonate use Laslett [24] 2014 Yes vs no Decrease in WOMAC pain β 0.69 (–0.54 to 1.92) o
(N = 323) Decrease in WOMAC function β 0.05 (–3.85 to 3.95) o
Decrease in WOMAC stiffness β –0.24 (–0.75 to 0.27) o
Decrease in NRS after 3 and
4 years, but not 5 years
β –1.15 (–1.94 to –0.36) +
Glucosamine/
chondroitin use
Yang [38] 2015 Yes vs no MICD of WOMAC pain β 0.68 (–0.16 to 1.53) o
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MICD of WOMAC-PF β 1.28 (–1.23 to 3.79) o
(N = 1,625) MICD of WOMAC stiffness β 0.41 (0–0.82) o
History of HRS Riddle [30] 2012 Yes vs no Knee joint surgery RR 2.73 (0.93–8.07) o
(N = 4,670)
*Statistically significant association of the determinant with OA progression: + positive association, – negative association, o no association (adjusted for age and
sex if applicable).
β regression coefficient, CES-D Center for Epidemiologic Studies Depression scale, CI confidence interval, CIRS Cumulative Illness Rating Scale, CSQ Coping
Strategies Questionnaire, HR hazard ratio, HRS hip replacement surgery, K/L Kellgren and Lawrence score, KOOS-4 Knee injury and Osteoarthritis Outcome Score
for pain, symptoms, function and quality of life, LSMD least squares means difference, MICD minimally important clinical difference, N combined sample size, NRS
Numeric Rating Scale, NSAID non-steroidal anti-inflammatory drug, OA osteoarthritis, OR odds ratio, PCI Pain Coping Inventory, RR relative risk, SF-12 MCS Short
Form survey instrument for the Mental Component Summary, SF-36 HS/MOS SF-36 Health Survey/Medical Outcome Study, TWT Timed Walking Test, WOMAC-PF
physical function scale of the Western Ontario and McMaster osteoarthritis index
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Disease characteristics are show in Table 4. Multiple
studies were performed determining the associations for
baseline radiographic or clinical severity of OA [9, 13,
15, 21, 26, 27, 30, 34]. Bruyere et al. found an increased
risk for knee joint surgery in patients with an increased
rate of joint space narrowing per 3 years [13]. Collins
et al. [15], Riddle et al. [30] and Oak et al. [26] found sig-
nificant associations for both baseline radiographic sever-
ity and baseline pain. Alschuler et al. found associations
for baseline pain and function scores [9]. Pisters et al.
found a significant association between baseline pain in-
tensity and self-reported limitations on the WOMAC-PF
scale [27]. Sharma et al. determined a significantly positive
association for baseline VAS pain score [34]. Holla et al.
found significant associations for baseline osteophytosis
and NRS for pain [21].
Riddle et al. found that a painful knee flexion and a
flexion contracture were significantly associated with
future knee joint surgery, but knee joint line tenderness
was not associated [30]. Holla et al. did find an associ-
ation for bony tenderness [21]. Pisters et al. [27] and
Holla et al. [21] reported that a larger baseline knee
range of motion (ROM) was significantly associated with
less knee cOA progression. Muraki et al. studied hand
grip strength in participants with knee cOA progression,
as an indication of general muscle strength, and found
no significant associations [25].
Three authors studied the association between quadri-
ceps strength and cOA progression [10, 27, 30]. Only
one study found an association, describing significantly
lower mean baseline quadriceps strength in patients with
cOA progression [30].
Scher et al. found a significant association for MRI-
detected global bone marrow edema [33]. Roemer et al.
found an association in knees with more than two subre-
gions with bone marrow lesions (BMLs), but no associ-
ation when scoring BMLs [32]. Tanamas et al. investigated
the association for BMLs in the tibiofemoral joint [35].
They found significant associations for the total presence
of BMLs and for medial BMLs. The association for lateralBMLs was not statistically significant. The authors also
found an association for MRI-detected subchondral bone
cysts in the medial tibiofemoral compartment, but not for
the lateral compartment [36].
MRI-detected cartilage loss and the risk of cOA pro-
gression was studied by four authors [14, 17, 32, 33].
Cicuttini et al. reported a significant association between
cartilage loss rate >8 % per annum and knee joint
surgery [14]. Eckstein et al. found significant positive as-
sociations for increased cartilage thickness loss in the
medial tibiofemoral compartment [17]. They found no
significant association in the lateral compartment. Simi-
lar significant associations were found in their analyses
when calculating the percentage denuded area of sub-
chondral bone in the medial compartment (data not pre-
sented in this review). Roemer et al. found elevated risks
in knees that exhibited ≥2 compartments with severe
cartilage loss on MRI [32]. Scher et al. found no signifi-
cant associations [33].
Roemer et al. found an association with knee joint sur-
gery in knees with MRI-detected medial meniscus macer-
ation, but not for lateral maceration or meniscal extrusion
[32]. Amin et al. found no significant association for MRI-
detected anterior cruciate ligament tear [11].
Hill et al. found significant correlations for the pres-
ence of MRI-detected infrapatellar and intercondylar
synovitis at baseline [19]. The correlation for suprapatel-
lar synovitis was non-significant. Conaghan et al. found
no association for synovitis detected by ultrasonography
(US) [16]. They did report a significant association for
US-detected joint effusion [16]. Riddle et al. also re-
ported significant associations for clinically detected
joint effusion (positive bulge sign) [29, 30]. Roemer et al.
found associations for both MRI-detected effusion and
synovitis [32].
Podsiadlo et al. found that an increase in overall rough-
ness of medial tibial trabecular bone texture, or fractal di-
mension, detected on fractal signal analysis led to a risk
reduction for knee joint surgery [28]. All other fractal di-
mension regions of interest showed non-significant associ-
ations (data not presented in Table 4).
Table 4 Disease characteristics studied as determinants for clinical knee OA progression in the included studies
Determinant Author [ref.] year Analysis of determinant Definition of knee OA
progression
OR/RR/HR/β
(95 % CI)
Association with
OA prognosis*
Severity
Radiographic Bruyere [13] 2005 JSN ≥0.5 mm/3 years Knee joint surgery RR 4.61 (1.65–12.8) +
(N = 8,201) Riddle [30] 2012 Per grade (0–4 grade scale) Knee joint surgery RR 2.09 (1.63–2.69) +
Collins [15] 2014 K/L 3 vs K/L 2a Severe vs no pain
WOMAC pain trajectory
OR 4.3 (2.1–8.6) +
Holla [21] 2014 Osteophytosis Poor vs good outcome
WOMAC-PF trajectory
OR 5.68 (2.57–12.55) +
Oak [26] 2013 Baseline JSW (mm) Decrease KOOS pain
(KOOS symptom and
quality of life show similar
regression coefficients)
β 1.94 (1.19–2.69) +
JSN over 4 years (mm) β 2.31 (1.18–3.44) +
Clinical Alschuler [9] 2013 NRS of past 7 daysa ≥20 % change in
combined NRS and
WOMAC-PF score
Not provided +
(N = 7,558) WOMAC-PFa Not provided +
Holla [21] 2014 NRS for knee paina Poor vs good outcome
WOMAC-PF trajectory
OR 1.81 (1.51–2.16) +
Oak [26] 2013 Baseline KOOS value Decrease KOOS pain
(KOOS symptom and
quality of life show similar
regression coefficients)
β 0.49 (0.43–0.59) +
Pisters [27] 2012 Per cm increase VASa Increase in self-reported
limitations (WOMAC-PF)
β 5.99 (2.90–12.4) +
Sharma [34] 2003 Per 20 mm VAS increase Progressing/remaining in
poor WOMAC-PF quintiles
OR 1.48 (1.12–1.95) +
Riddle [30] 2012 NRS of past 30 daysa Knee joint surgery RR 1.12 (1.02–1.22) +
Painful knee flexion Riddle [30] 2012 Yes vs no Knee joint surgery RR 1.58 (1.04–2.39) +
(N = 4,670)
Joint line tenderness Holla [21] 2014 Yes vs no Poor vs good outcome
WOMAC-PF trajectory
OR 2.63 (1.38–5.02) +
(N = 5,367) Riddle [30] 2012 Yes vs no Knee joint surgery RR 0.71 (0.43–1.18) o
Flexion contracture Riddle [30] 2012 Knee flexion contracture (°) Knee joint surgery RR 1.06 (1.02–1.11) +
(N = 4,670)
Knee ROM Holla [21] 2014 Active ROM in degrees Poos vs good outcome
WOMAC-PF trajectory
OR 0.96 (0.93–1.00) –
(N = 913) Pisters [27] 2012 Mean extension Increase in performance-
based limitations (TWT)
β 0.92 (0.86–0.98) –
Hand grip strength
(muscle strength)
Muraki [25] 2012 Per 1 kg strength increase Incident knee pain at
follow-up (baseline
K/L ≥2)
OR 1.00 (0.98–1.02) o
(N = 1,313)
Quadriceps strength Amin [10] 2009 Low vs middle Increase in knee specific
VAS pain score
Not provided o
(N = 5,151) vs high strength Increase in self-reported
limitations (WOMAC-PF)
Not provided o
Pisters [27] 2012 Continuous in Newton/kg Increase in self-reported
limitations (WOMAC-PF)
β 0.11 (0.01–1.36) o
Increase in performance-
based limitations (TWT)
β 0.60 (0.37–1.03) o
Riddle [30] 2012 Normalized to bodyweight Knee joint surgery RR 0.79 (0.65–0.96) –
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Table 4 Disease characteristics studied as determinants for clinical knee OA progression in the included studies (Continued)
Bone marrow lesions/
edema (BMLs/BME)
Roemer [32] 2014 ≥2 subregions vs 0–1 Knee joint surgery OR 4.00 (1.75–9.16) +
Grade ≥1 vs grade 0 OR 4.00 (0.85–18.84) o
Scher [33] 2008 Global BME vs none Knee joint surgery OR 15.2 (2.38–97.1) +
(N = 580) Tanamas [35] 2010 BMLs, present vs absent Knee joint surgery OR 1.57 (1.04–2.35) +
Medial BMLs vs absent Knee joint surgery OR 1.78 (1.16–2.74) +
Lateral BMLs vs absent Knee joint surgery OR 0.82 (0.43–1.54) o
Subchondral bone
cysts (MRI)
Tanamas [36] 2010 Medial, per grade of severity Knee joint surgery OR 1.99 (1.01–3.90) +
Lateral, per grade of severity Knee joint surgery OR 0.96 (0.48–1.94) o
(N = 109)
Cartilage loss (MRI) Cicuttini [14] 2004 Rate 3–8 % per annum Knee joint surgery OR 2.3 (0.4–12.2) o
(N = 681) Rate >8 % per annum OR 7.1 (1.4–36.5) +
Eckstein [17] 2013 Change in cMFTC.ThC Knee joint surgery Not provided +
Change in MFTC.ThC Not provided +
Change in LFTC.ThC Not provided o
Roemer [32] 2014b Grade 3 vs <3 (whole knee) OR 4.00 (2.23–7.18) +
Grade 3 vs 0 (MFTC) Knee joint surgery OR 3.01 (1.52–5.95) +
Grade 3 vs 0 (LFTC) OR 1.69 (0.94–3.02) o
Scher [33] 2008 ≥50 % vs <50 % loss Knee joint surgery OR 2.06 (0.74–5.70) o
Meniscal extrusion
(MRI)
Roemer [32] 2014 ≥5 mm vs <5 mm (medial) Knee joint surgery OR 1.00 (0.60–1.67) o
≥5 mm vs <5 mm (lateral) OR 1.42 (0.54–3.75) o
(N = 398)
Meniscal damage
(MRI)
Roemer [32] 2014 Grade 6–8 vs 0–1 (medial) Knee joint surgery OR 1.84 (1.13–2.99) o
(N = 398) Grade 6–8 vs 0–1 (lateral) OR 1.10 (0.68–1.77) o
Anterior cruciate
ligament tear
Amin [11] 2008 Complete tear on MRI Increase in knee-specific
VAS pain score
Not provided o
Complete tear on MRI Increase in self-reported
limitations (WOMAC-PF)
Not provided o
(N = 265)
Synovitis Roemer [32] 2014 Infrapatellar fat pad on MRI Knee joint surgery OR 2.17 (1.33–3.56) +
(N = 764) Hill [19] 2007 Infrapatellar fat pad on MRI Increase in knee-specific
VAS pain score
β 4.89 (0.42–9.36) +
Intercondylar on MRI β 5.74 (0.34–11.14) +
Suprapatellar on MRI β 3.35 (–0.34 to 7.05) o
Conaghan [16] 2010 Present on US Knee joint surgery HR 1.54 (0.95–2.50) o
Joint effusion Conaghan [16] 2010 Present on US Knee joint surgery HR 3.06 (2.00–4.69) +
(N = 5,979) Riddle [29] 2009 Positive bulge sign Knee joint surgery OR 2.53 (1.13–5.56) +
Riddle [30] 2012 Positive bulge sign Knee joint surgery RR 1.58 (1.04–2.40) +
Roemer [32] 2014 Present on MRI (grade 1–3) Knee joint surgery OR 4.75 (2.55–8.85) +
Trabecular bone
texture
Podsiadlo [28] 2014 FDmean on FSA, medial Knee joint surgery OR 0.23 (0.06–0.82) +
(N = 114) FDmean on FSA, lateral OR 0.33 (0.09–1.22) o
C2C (serum) Berry [12] 2009 High level vs low Knee joint surgery OR 1.01 (0.94–1.08) o
(N = 117)
COMP (serum) Berry [12] 2010 High level vs low Knee joint surgery OR 0.77 (0.15–3.81) o
(N = 117)
PIIANP (serum) Berry [12] 2010 Natural log baseline levels Knee joint surgery OR 0.28 (0.10–0.93) –
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Table 4 Disease characteristics studied as determinants for clinical knee OA progression in the included studies (Continued)
(N = 117)
ARGS (synovial) Larsson [23] 2012 Baseline level ARGS >
follow-up level ARGS
≥10 units progression
KOOS Pain
OR 3.66 (1.01–13.2) +
(N = 74) ≥10 units progression
KOOS Function of daily
living
OR 1.11 (0.26–4.80) o
*Statistically significant association of the determinant with OA progression: + positive association, – negative association, o no association (adjusted for age and
sex if applicable). aAssessed at baseline. bSimilar results found when measuring compartment cartilage thickness. ARGS aggrecan neoepitope amino acid sequence,
β regression coefficient, CI confidence interval, (c)MFTC.ThC (central) medial femorotibial compartment cartilage thickness (in mm), FDmean mean fractal dimension, FSA
fractal signal analysis, C2C collagen type-II cleavage, COMP cartilage oligomeric matrix protein, HR hazard ratio, JSN joint space narrowing, JSW joint space width, K/L
Kellgren and Lawrence score, KOOS Knee Injury and Osteoarthritis Outcome Score, LFTC lateral FTC, N combined sample size, MRI magnetic resonance imaging, NRS
Numeric Rating Scale, OA osteoarthritis, OR odds ratio, PIIANP N-propeptide of type IIA collagen, ROM range of motion, RR relative risk, TWT Timed Walking Test, US
ultrasonography, VAS Visual Analogue Scale, WOMAC-PF physical function scale of the Western Ontario and McMaster osteoarthritis index
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serum markers and cOA progression [12]. They found
no association for serum collagen type-II cleavage (C2C)
or for serum levels of cartilage oligometric matrix pro-
tein (COMP). They did find that serum N-propeptide of
type II collagen was associated with a significantly re-
duced risk for knee joint replacement.
Larsson et al. found an association between synovial
fluid aggrecan neoepitope amino acid sequence (ARGS)
levels and pain progression, but not between ARGS
levels and function of daily living [23].
Best evidence synthesis
Pooling was not possible due to heterogeneity, hence we
were forced to apply a best evidence synthesis (Table 5),
which demonstrated strong evidence that age, ethnicity,
BMI, co-morbidity count, MRI-detected infrapatellar syno-
vitis, joint effusion and baseline OA severity (both radio-
graphic and clinical) are associated with the progression of
clinical knee OA. There was moderate evidence showing
that education level, vitality, pain-coping subscale resting,
MRI-detected medial femorotibial cartilage loss and gen-
eral BMLs are associated with knee cOA progression.
There is limited evidence that pain coping subscales
worrying, hoping and catastrophizing, knee injury, knee
surgery, bisphosphonate usage, painful knee flexion,
flexion contracture, knee ROM, medial BMLs, medial
subchondral bone cysts and medial trabecular bone tex-
ture are associated with the cOA progression. There is
also limited evidence that there is no association between
clinical knee OA progression and knee compression force,
pain coping subscale distraction, morning stiffness, pain
medication usage, glucosamine or chondroitin usage, hip
replacement surgery, joint line tenderness, muscle strength,
lateral BMLs, lateral subchondral bone cysts, lateral femor-
otibial cartilage loss, meniscal extrusion or damage, anter-
ior cruciate ligament tear, synovitis other than infrapatellar,
lateral trabecular bone texture, and serum markers C2C
and COMP.
Conflicting evidence was found for the associations be-
tween clinical knee OA progression and gender, mentalhealth, bisphosphonate usage, joint line tenderness, quad-
riceps strength, MRI-detected whole knee cartilage loss
and synovial marker ARGS. There was inconclusive evi-
dence for the associations found between cOA progres-
sion and bodyweight change.
Sensitivity analysis
No conclusions were influenced or altered by differences
in sample size or follow-up duration. When analyzing
the definitions for cOA progression, we found irregular-
ity in the strong evidence found for age as a risk factor.
Five out of six studies found significant associations with
clinical knee OA progression. Three of these five associ-
ations were negative associations (i.e., lower baseline age
resulted in higher risk for progression); the remaining
two associations were positive associations. However,
these two positive associations defined cOA progression
as knee joint surgery, where the other three negative as-
sociations defined cOA progression by pain or function
scores. By splitting these definitions of cOA progression,
the evidence for age would remain strong, but lower age
would be labeled as a risk factor for more severe symp-
tom progression and higher age would be labeled as a
risk factor for knee joint surgery due to OA.
Discussion
There is strong evidence that age, ethnicity, BMI, co-
morbidity count, MRI-detected infrapatellar synovitis,
joint effusion and both radiographic and clinical base-
line OA severity are predictive for clinical knee OA
progression. However, for the majority of studied deter-
minants in our review the evidence is limited, conflict-
ing or inconclusive.
More precise estimates of associations could have been
given if pooling was possible, but this was not feasible
due to large variation in criteria for defining disease
(progression). Six different criteria were used for inclusion
of OA (see Table 2) and nine definitions were applied for
cOA progression (see Tables 3 and 4). Furthermore, vari-
ables under study were measured differently (continuous,
dichotomous, or categorical with varying cut-off points).
Table 5 Results from the best evidence synthesis: associations with clinical knee OA progression
Determinants Level of evidence
Age, ethnicity, BMI, co morbidity count, MRI-detected infrapatellar synovitis, joint effusion and baseline OA severity
(radiographic and clinical)
Strong evidence for association
Education level, vitality, pain coping subscale resting, MRI-detected medial femorotibial cartilage loss and
general BMLs
Moderate evidence for
association
Pain coping subscales worrying, hoping and catastrophizing, knee injury, knee surgery, bisphosphonate usage,
painful knee flexion, flexion contracture, knee ROM, medial BMLs, medial subchondral bone cysts and medial
trabecular bone texture
Limited evidence for association
Knee compression force, pain coping subscale distraction, morning stiffness, pain medication usage, glucosamine
or chondroitin usage, hip replacement surgery, joint line tenderness, muscle strength, lateral BMLs, lateral
subchondral bone cysts, lateral femorotibial cartilage loss, meniscal extrusion or damage, anterior cruciate ligament
tear, intercondylar or suprapatellar synovitis on MRI, synovitis on US, lateral trabecular bone texture serum markers
C2C and COMP
Limited evidence for no
association
Gender, mental health, bisphosphonate usage, joint line tenderness, quadriceps strength, MRI-detected whole knee
cartilage loss and synovial marker ARGS
Conflicting evidence
Bodyweight change Inconclusive evidence
ARGS aggrecan neoepitope amino acid sequence, BMI body mass index, BML, bone marrow lesion, C2C collagen type-II cleavage, COMP cartilage
oligomeric matrix protein, MRI magnetic resonance imaging, OA osteoarthritis, ROM range of motion, US ultrasonography
Bastick et al. Arthritis Research & Therapy  (2015) 17:152 Page 11 of 13Age has previously been recognized as a risk factor for
progression on symptomatic knee OA by van Dijk et al.
[39]. In this 2006 review determining prognostic factors
for functional status in knee OA, the authors presented
similar evidence on age as a risk factor. Oddly enough,
as presented in our sensitivity analysis, a lower baseline
age is associated with an increased risk of symptom pro-
gression, whereas a higher baseline age results in an in-
creased risk for undergoing knee joint surgery due to
knee OA. This inverse association is not properly under-
stood yet and should be explored in future studies.
Overweight has previously been recognized as a risk
factor for incident knee OA [40, 41]. The evidence for
an association between overweight and progression of
radiographic knee OA remains conflicting [2, 42], but
this review shows strong evidence for the association be-
tween BMI and symptom progression which is in line
with earlier findings by van Dijk et al. [39].
An association between knee pain and joint effusion
has been found before in cross-sectional analysis, but
the exact pathophysiology needs to be better understood
[43]. Previous reviewers found similar results for MRI-
detected effusion or synovitis, but these results are based
on cross-sectional studies or on the same longitudinal
studies included in this review [44]. Our results show
that joint effusion, which is relatively easy and cheap to
ascertain in primary care by physical examination or US,
seems to be a strong predictor of symptom progression
and it underlines the importance of proper physical
examination.
High baseline OA severity scores were associated with
clinical knee OA progression. It seems logical that sub-
jects with initial severe symptoms are prone to symptom
progression, but there is a discrepancy in the evidence
for radiographic OA severity and symptom severity [45].In this 2009 review of the (mainly cross-sectional) litera-
ture the authors however state that many studies have
not used X-ray views of all three compartments of the
knee, which could have contributed to an underestima-
tion of the association between radiographic knee OA
and clinical symptoms [45].
We found notable overlap with the evidence for
clinical hip OA progression in two large reviews, defin-
ing clinical hip OA progression as total hip arthroplasty
(THA) [5, 46]. The authors presented conflicting evi-
dence regarding age and gender, but consistent evidence
for associations between both radiographic and clinical
baseline severity with THA. Moreover, there was limited
evidence for an association between BMI and no associ-
ation between serum COMP with THA.
A point of discussion could be our choice of outcome
measure inclusion, i.e., including and comparing pain
progression, physical function decline and knee joint
surgery. Although these measures are not the same, there
exists a strong correlation between these outcomes. More-
over, presenting these results together provides a clear
overview of all existing evidence regarding symptomatic
knee OA progression. One observation that strongly be-
comes apparent is the lack of studies investigating risk
factors for pain progression in knee OA, when pain has
shown to be the number one complaint in patients with
(knee) OA [1]. On the other hand, pain is an important in-
dication for undergoing knee joint surgery, which will be
further addressed below.
Our study may have limitations. Firstly, limitations to
reviewing observational studies on disease progression
have been addressed, stating that, unlike randomized tri-
als, observational studies of pre-existing disease are sub-
ject to various biases that may account for discrepancies
found between risk factors for incidence and progression
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progressive knee OA, but that flaws in study design and
the measure of disease progression may prevent true
detection of risk factors [47]. Secondly, some outcome
measures were only assessed once at follow-up, which
consequently could have led to an incorrect assessment
of true clinical OA progression. Pain and physical limita-
tions due to OA fluctuate over time, hence multiple out-
come measure assessments during follow-up would give
a better depiction of disease progression [48]. Finally,
using knee joint surgery as an outcome measure for
clinical knee OA progression might lead to discussion,
considering orthopedic surgeons would generally not op-
erate on a knee that shows no sign of (progressed) radio-
graphic OA. However, studies have shown that a key
indicator for undergoing knee joint surgery in patients
with knee OA is pain or disability [30, 49].
When comparing our results to the results found in
the review by Belo et al. [2], substantial differences in
prognostic factors for cOA progression can be detected
compared to risk factors for radiographic progression of
knee OA. Belo et al., for instance, found strong evidence
for no association for gender and quadriceps strength,
when we found conflicting evidence for both determi-
nants. Moreover, there are differences in the number of
investigated possible risk factors. For example, Belo et al.
found strong evidence for the association of serum levels
of hyaluronic acid with radiographic knee OA progres-
sion, when no articles investigating hyaluronic acid were
included in this current review. The abovementioned
underlines the importance of distinguishing (possible)
risk factors for clinical knee OA progression from (pos-
sible) risk factors for radiographic knee OA progression.
More research is needed on the true relationship be-
tween prognostic factors for symptomatic knee OA pro-
gression, especially regarding factors where conflicting,
limited or inconclusive evidence was presented. It would
be very convenient if a physician was enabled to closely
monitor patients with symptomatic knee OA who are at
high risk for rapid or severe symptom progression. More-
over, potential risk factors which can be modified at an
early stage of the disease, i.e., pain coping strategies or
quadriceps strength, could prove to have substantial bene-
fit in the treatment of patients with knee OA. In addition,
the etiology and pathophysiology of radiographic OA fea-
tures, joint effusion, BMLs and subchondral cysts in knee
OA and their relation with clinical symptoms longitudin-
ally should be further explored.
Conclusions
In conclusion, we have summarized the available evidence
of prognostic factors for clinical knee OA progression. A
large variety in definitions of clinical knee OA (progres-
sion) remains, which unfortunately makes it impossible toproperly summarize the evidence through meta-analyses.
More research on prognostic factors for knee OA is
needed using symptom progression as an outcome meas-
ure. There are remarkably few studies that study pain pro-
gression in patients with knee OA.
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